NFATC1 and neoplasm: Our results demonstrated that low expression of NFATc1 was correlated with larger tumor size (P = 0.020), advanced TNM stage (P = 0.001), higher serum AFP levels (P = 0.021), and liver cirrhosis (P = 0.033).